Related Experiment Videos
Low plasma beta-endorphin in post-traumatic stress disorder
L Hoffman1, P Burges Watson, G Wilson
1Repatriation General Hospital, Hobart, Tasmania.
The Australian and New Zealand Journal of Psychiatry
|June 1, 1989
Summary
Post-Traumatic Stress Disorder (PTSD) patients exhibit elevated morning serum cortisol and reduced plasma beta-endorphin levels compared to controls. This suggests beta-endorphin may serve as a biomarker for PTSD, potentially linked to opioid depletion in the disorder.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Clinical Psychology
Background:
- Post-Traumatic Stress Disorder (PTSD) is a complex mental health condition.
- Neuroendocrine system dysregulation is implicated in PTSD.
- Cortisol and opioid peptides are key stress-related hormones.
Purpose of the Study:
- To investigate differences in serum cortisol, ACTH, and plasma beta-endorphin between PTSD patients and healthy controls.
- To explore the potential role of these hormones in PTSD pathophysiology.
Main Methods:
- Serum cortisol, ACTH, and plasma beta-endorphin levels were measured in 21 PTSD patients and 20 controls.
- Diurnal rhythm disturbances were assessed.
- Hormone levels were compared between groups.
Main Results:
- No significant disturbances in diurnal rhythms were observed.
- PTSD patients showed significantly higher morning serum cortisol levels than controls.
- Both morning and evening plasma beta-endorphin levels were significantly lower in PTSD patients compared to controls.
Conclusions:
- Plasma beta-endorphin may serve as a potential biomarker for PTSD.
- Chronic endogenous opioid depletion could contribute to the development and maintenance of PTSD.
- Further research into neuroendocrine alterations in PTSD is warranted.